Morrone Luigi Antonio, Rombolà Laura, Corasaniti Maria Tiziana, Bagetta Giacinto, Nucci Carlo, Russo Rossella
Department of Pharmacy and Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, University of Calabria, Arcavacata di Rende, Italy; University Consortium for Adaptive Disorders and Head Pain (UCHAD), Section of Neuropharmacology of Normal and Pathological Neuronal Plasticity, University of Calabria, Arcavacata di Rende, Italy.
Department of Pharmacy and Health and Nutritional Sciences, Section of Preclinical and Translational Pharmacology, University of Calabria, Arcavacata di Rende, Italy.
Prog Brain Res. 2015;220:257-81. doi: 10.1016/bs.pbr.2015.05.004. Epub 2015 Jun 30.
Glaucoma, the second leading cause of blindness in the world, is a chronic optic neuropathy often associated with increased intraocular pressure and characterized by progressive retinal ganglion cell (RGC) axons degeneration and death leading to typical optic nerve head damage and distinctive visual field defects. Although the pathogenesis of glaucoma is still largely unknown, it is hypothesized that RCGs become damaged through various insults/mechanisms, including ischemia, oxidative stress, excitotoxicity, defective axonal transport, trophic factor withdrawal, and neuroinflammation. In this review, we summarize the potential benefits of several natural compounds for RGCs neuroprotection.
Prog Brain Res. 2015
Gene Ther. 2011-10-6
Annu Rev Vis Sci. 2017-7-21
Int J Mol Sci. 2024-2-29
Commun Biol. 2021-6-3
Pharmaceutics. 2020-12-26
Int J Mol Sci. 2020-5-7
Prog Retin Eye Res. 2018-2-23
Curr Neuropharmacol. 2018